세계의 의약품 시리얼라이제이션(Serialization) 서비스 시장 : 규모, 점유율, 동향 분석(포장별, 제품별, 기술별, 지역별), 부문별 예측(2025-2030년)

Pharmaceutical Serialization Services Market Growth & Trends:

The global pharmaceutical serialization services market size is expected to reach USD 29.35 billion by 2030, growing at a CAGR of 12.28% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by growing threat of counterfeit drugs, continuous advancements in technology and automation, growing regulatory compliance and government mandates, among others. Stringent regulations such as the U.S. Drug Supply Chain Security Act (DSCSA) and EU Falsified Medicines Directive (FMD) mandated the serialization and track-and-trace systems which further contributed to the overall market growth.

Furthermore, increasing prevalence of counterfeit drugs is also one of the factors contributing to the market growth. According to the data published by the U.S. FDA in November 2024, approximately 10% of medicines in low- and middle-income countries are falsified or substandard. Serialization technologies, such as barcode scanning, RFID tags, and blockchain-based track-and-trace systems, help manufacturers and distributors authenticate drug products throughout the supply chain. By enhancing transparency and security, serialization will enable fasted recalls, reduce revenue losses, and strengthen consumer confidence in legitimate pharmaceutical brands.

Furthermore, technological advancements in serialization solutions are further propelling market growth. Automation, artificial intelligence (AI), and cloud-based serialization platforms are improving efficiency and scalability in drug tracking. Advanced data analytics integrated with serialization systems are assisting pharmaceutical companies to optimize supply chain management, detect abnormalities, and predict potential disruptions. Additionally, the growing adoption of the Internet of Things (IoT) in pharmaceutical logistics are enhancing real-time monitoring of drug shipments, enhancing compliance with storage conditions and regulatory standards. As digital transformation accelerates across the healthcare industry, pharmaceutical companies are increasingly leveraging smart serialization technologies to gain a competitive edge and improve operational efficiency.

Key players in the pharmaceutical serialization services market are considering several strategic initiatives such as mergers and acquisitions (M&A), partnerships, and geographic expansion to strengthen their global market position. Companies such as Systech International, OPTEL Group, and Zebra Technologies are enhancing their capabilities by acquiring complementary technology firms and expanding their product portfolios. Through M&A, these companies aim to integrate advanced serialization technologies and broaden their customer base, while also gaining access to new markets. For instance, in June 2024, Systech launched a new turnkey solution aimed at streamlining pharmaceutical rework and manual aggregation processes. This solution is designed to help pharmaceutical companies manage product recalls, rework, and aggregation tasks efficiently, ensuring compliance with serialization and track-and-trace regulations.

Pharmaceutical Serialization Services Market Report Highlights:

• Based on packaging, primary packaging dominated the market owing to its direct interaction with the drug product and its crucial role in ensuring the safety and integrity of medicine
• Based on the product, hardware held the largest market share in 2024, Hardware solutions, including barcode scanners, RFID systems, printers, and inspection machines, are fundamental for capturing, reading, and verifying serialized data on pharmaceutical packaging
• Based on technology, barcodes held the largest market share in 2024 due to their cost-effectiveness, ease of implementation, and widespread adoption across the industry. Barcodes, including 1D and 2D (QR codes), are widely used for product identification, serialization, and traceability in the pharmaceutical supply chain

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
• 1.6. Data Analysis Models
  • 1.6.1. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Parent Market Analysis
• 1.8. List Of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives
  • 1.10.1. Objective-1
  • 1.10.2. Objective-2
  • 1.10.3. Objective-3

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
  • 3.3.2. Market Restraint Analysis
• 3.4. Technology Landscape
• 3.5. Pricing Model Analysis
• 3.6. Industry Analysis Tools
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. PESTEL Analysis
  • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Serialization Services Market Estimates and Forecasts: Packaging Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Pharmaceutical Serialization Services Market; Packaging Movement Analysis
• 4.3. Pharmaceutical Serialization Services Size & Trend Analysis, by Packaging, 2018 to 2030 (USD Million)
• 4.4. Primary Packaging
  • 4.4.1. Primary packaging Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 4.5. Generic
  • 4.5.1. Generic Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 4.6. Secondary Packaging
  • 4.6.1. Secondary packaging Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 4.7. Tertiary Packaging
  • 4.7.1. Tertiary packaging Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 5. Pharmaceutical Serialization Services Market Estimates and Forecasts: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Pharmaceutical Serialization Services Market; Product Movement Analysis
• 5.3. Pharmaceutical Serialization Services Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 5.4. Hardware
  • 5.4.1. Hardware Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 5.5. Software
  • 5.5.1. Software Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 6. Pharmaceutical Serialization Services Market Estimates and Forecasts: Technology Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Pharmaceutical Serialization Services Market; Technology Movement Analysis
• 6.3. Pharmaceutical Serialization Services Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
• 6.4. Barcodes
  • 6.4.1. Barcodes Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 6.5. Radiofrequency Identification (RFID) Tags
  • 6.5.1. Radiofrequency Identification (RFID) Tags Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 6.6. Real-time Locating System
  • 6.6.1. Real-Time Locating System Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 7. Pharmaceutical Serialization Services Market Estimates and Forecasts: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. North America Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. U.S. Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Canada Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. Mexico Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. Germany Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.4.3. UK
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. UK Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. France Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Italy Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Spain Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. Denmark Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Framework
    • 7.4.8.4. Sweden Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Framework
    • 7.4.9.4. Norway Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Japan Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. China Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. India Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. South Korea Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Australia Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Thailand Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Brazil Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Argentina Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. South Africa Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Saudi Arabia Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. UAE Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Kuwait Pharmaceutical Serialization Services Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
  • 8.1.1. Market Leaders
  • 8.1.2. Emerging Players
• 8.2. Company Market Share/Assessment Analysis, 2024
• 8.3. Company Profiles
  • 8.3.1. Systech International
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Service benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. OPTEL Group
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Service benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Arvato Systems
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Service benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. SEA Vision
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Service benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. LSPedia
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Service benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Innovatum. Inc.
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Service benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Wipotec
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Service benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Mettler-Toledo
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Service benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. ZetesAtlas for Pharma
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Service benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Abacus Medicine
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Service benchmarking
    • 8.3.10.4. Strategic initiatives